GE HealthCare Technologies Inc.
GE HealthCare Technologies Inc. (GEHC): 14 pipeline candidates · 1 upcoming catalyst · ~10 mo cash runway · 5 clinical trials. Updated within the last hour.
BioSniper Score
6-factor signal · derived from public data
9.7 months
D/E 2.46
Lead: Approved
14 candidates
1 upcoming, next in ~821d
8 buys · 0 sells (180d)
A transparent, data-derived signal for GE HealthCare Technologies Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$29.6B
Cash
$2.3B
Quarterly Burn
$1.5B
Runway
9.7 mo
Revenue
$5.1B
Cash Runway vs Catalysts
A catalyst falls after projected cash runway — potential financing / dilution risk before it hits.
Pipeline (14 candidates)
Showing 10 of 14 candidates. Sign up for full pipeline.
Upcoming Catalysts (1)
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
1,258
Total value held
$28.04B
| Holder | Shares | Value |
|---|---|---|
| vanguard capital management llc | 57,728,376 | $4.11B |
| blackrock, inc. | 35,984,327 | $2.56B |
| dodge & cox | 31,312,064 | $2.23B |
| state street corp | 20,538,476 | $1.46B |
| vanguard portfolio management llc | 19,183,157 | $1.37B |
| harris associates l p | 15,594,988 | $1.11B |
| geode capital management, llc | 12,399,635 | $879.3M |
| barrow hanley mewhinney & strauss llc | 11,884,588 | $845.9M |
| hotchkis & wiley capital management llc | 9,967,873 | $709.5M |
| jpmorgan chase & co | 8,964,669 | $616.5M |
Showing top 10 of 1,258 institutional holders of GE HealthCare Technologies Inc.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in GE HealthCare Technologies Inc.'s pipeline?
GE HealthCare Technologies Inc. (GEHC) has 14 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is GE HealthCare Technologies Inc.'s lead drug candidate?
GE HealthCare Technologies Inc.'s most advanced tracked candidate is achilles insight ultrasonometer (Approved) for Radiology.
What is GE HealthCare Technologies Inc.'s next catalyst?
GE HealthCare Technologies Inc.'s next tracked catalyst is a Patent_Expiry event — "Patent/Exclusivity Expiry: VIZAMYL" — expected September 16, 2028.
What is GE HealthCare Technologies Inc.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, GE HealthCare Technologies Inc. has approximately 9.7 months of cash runway.
What is GE HealthCare Technologies Inc.'s market capitalization?
GE HealthCare Technologies Inc.'s market capitalization is approximately $29.6B.
Get the full picture on GE HealthCare Technologies Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.